The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial–mesenchymal transition in mammary epithelial and in breast cancer cells

Cancer Letters

Volumn 396, Issue , 2017, Pages 42-52

  Monteiro, Fátima Liliana ^a,b   Vitorino, Rui ^a   Wang, Jun ^c   Cardoso, Hugo ^a   Laranjeira, Hugo ^a   Simões, Joana ^a   Caldas, Margarida ^b   Henrique, Rui ^b,d   Amado, Francisco ^a   Williams, Cecilia ^c,e,f   Jerónimo, Carmen ^b,d   Helguero, Luisa A ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c University of Houston   (United States)

^d UNIVERSITY OF PORTO   (Portugal)

^e ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Epidermal growth factor; Epithelial mesenchymal transition; Hist2h2ac; Histone H2A variants; Mammary epithelial cells

Indexed keywords

CD24 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; HISTONE; ISOPROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; CANONICAL ANALYSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE AMPLIFICATION; GENE SILENCING; GENE TARGETING; HIST2H2AC GENE; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR SUPPRESSOR GENE; BREAST; BREAST TUMOR; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HISTONES; HUMANS; MASS SPECTROMETRY; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 85015871656     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2017.03.007     Document Type: Article

References (33)

1. [1] Marzluff, W.F., Wagner, E.J., Duronio, R.J., Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet. 9 (2008), 843–854, 10.1038/nrg2438.
2. [2] Talbert, P.B., Henikoff, S., Histone variants–ancient wrap artists of the epigenome. Nat. Rev. Mol. Cell Biol. 11 (2010), 264–275, 10.1038/nrm2861.
3. [3] Soboleva, T.A., Nekrasov, M., Ryan, D.P., Tremethick, D.J., Histone variants at the transcription start-site. Trends Genet. 30 (2014), 199–209, 10.1016/j.tig.2014.03.002.
4. [4] Singh, R., Harshman, S.W., Ruppert, A.S., Mortazavi, A., Lucas, D.M., Thomas-Ahner, J.M., et al. Proteomic profiling identifies specific histone species associated with leukemic and cancer cells. Clin. Proteomics, 12, 2015, 22, 10.1186/s12014-015-9095-4.
5. [5] Singh, R., Mortazavi, A., Telu, K.H., Nagarajan, P., Lucas, D.M., Thomas-Ahner, J.M., et al. Increasing the complexity of chromatin: functionally distinct roles for replication-dependent histone H2A isoforms in cell proliferation and carcinogenesis. Nucleic Acids Res. 41 (2013), 9284–9295, 10.1093/nar/gkt736.
6. [6] Huang, T.H.-M., Esteller, M., Chromatin remodeling in mammary gland differentiation and breast tumorigenesis. Cold Spring Harb. Perspect. Biol., 2, 2010, a004515, 10.1101/cshperspect.a004515.
7. [7] Lønning, P.E., Sørlie, T., Børresen-Dale, A.-L., Genomics in breast cancer-therapeutic implications. Nat. Clin. Pract. Oncol. 2 (2005), 26–33, 10.1038/ncponc0072.
8. [8] Monteiro, F.L.F.L., Baptista, T., Amado, F., Vitorino, R., Jerónimo, C., Helguero, L.A.L.A., Expression and functionality of histone H2A variants in cancer. Oncotarget 5 (2014), 3428–3443.
9. [9] Bönisch, C., Hake, S.B., Histone H2A variants in nucleosomes and chromatin: more or less stable?. Nucleic Acids Res. 40 (2012), 10719–10741, 10.1093/nar/gks865.
10. [10] Li, X., Kuang, J., Shen, Y., Majer, M.M., Nelson, C.C., Parsawar, K., et al. The atypical histone macroH2A1.2 interacts with HER-2 protein in cancer cells. J. Biol. Chem. 287 (2012), 23171–23183, 10.1074/jbc.M112.379412.
11. [11] Yao, J., Weremowicz, S., Feng, B., Gentleman, R.C., Marks, J.R., Gelman, R., et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res. 66 (2006), 4065–4078, 10.1158/0008-5472.CAN-05-4083.
12. [12] Srivastava, N., Gochhait, S., Gupta, P., Bamezai, R.N.K., Copy number alterations of the H2AFX gene in sporadic breast cancer patients. Cancer Genet. Cytogenet 180 (2008), 121–128, 10.1016/j.cancergencyto.2007.09.024.
13. [13] Nagelkerke, A., van Kuijk, S.J.A., Sweep, F.C.G.J., Nagtegaal, I.D., Hoogerbrugge, N., Martens, J.W.M., et al. Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer. Radiother. Oncol. 101 (2011), 39–45, 10.1016/j.radonc.2011.07.009.
14. [14] Zucchi, I., Mento, E., Kuznetsov, V.A., Scotti, M., Valsecchi, V., Simionati, B., et al. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 18147–18152, 10.1073/pnas.0408260101.
15. [15] Gévry, N., Hardy, S., Jacques, P.-E., Laflamme, L., Svotelis, A., Robert, F., et al. Histone H2A.Z is essential for estrogen receptor signaling. Genes Dev. 23 (2009), 1522–1533, 10.1101/gad.1787109.
16. [16] Svotelis, A., Gévry, N., Grondin, G., Gaudreau, L., H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle 9 (2010), 364–370.
17. [17] Jagannathan, R., Kaveti, S., Desnoyer, R.W., Willard, B., Kinter, M., Karnik, S.S., AT1 receptor induced alterations in histone H2A reveal novel insights into GPCR control of chromatin remodeling. PLoS One, 5, 2010, e12552, 10.1371/journal.pone.0012552.
18. [18] Williams, C., Helguero, L., Edvardsson, K., Haldosén, L.-A., Gustafsson, J.-A., Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression. Breast Cancer Res., 11, 2009, R26, 10.1186/bcr2256.
19. [19] Cotrim, C.Z.Z., Fabris, V., Doria, M.L.L., Lindberg, K., Gustafsson, J.-Å.J.-Å., Amado, F., et al. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Oncogene 32 (2013), 2390–2402, 10.1038/onc.2012.261.
20. [20] Shechter, D., Dormann, H.L., Allis, C.D., Hake, S.B., Extraction, purification and analysis of histones. Nat. Protoc. 2 (2007), 1445–1457, 10.1038/nprot.2007.202.
21. [21] Ferreira, R., Rocha, H., Almeida, V., Padrão, A.I., Santa, C., Vilarinho, L., et al. Mitochondria proteome profiling: a comparative analysis between gel- and gel-free approaches. Talanta 115 (2013), 277–283, 10.1016/j.talanta.2013.04.026.
22. [22] Helguero, L.A., Lindberg, K., Gardmo, C., Schwend, T., Gustafsson, J.-A., Haldosén, L.-A., Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line. Cancer Res. 68 (2008), 8695–8704, 10.1158/0008-5472.CAN-08-0788.
23. [23] Helguero, L.A.L.A., Faulds, M.H., Förster, C., Gustafsson, J.-Å.J.-A., Haldosén, L.-A.L.-A., Hedengran Faulds, M., et al. DAX-1 expression is regulated during mammary epithelial cell differentiation. Endocrinology 147 (2006), 3249–3259, 10.1210/en.2005-1651.
24. [24] Baptista, T., Graça, I., Sousa, E.J., Oliveira, A.I., Costa, N.R., Costa-Pinheiro, P., et al. Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer. Oncotarget 4 (2013), 1673–1685, 10.18632/oncotarget.1237.
25. [25] Clark, S.J., Statham, A., Stirzaker, C., Molloy, P.L., Frommer, M., DNA methylation: bisulphite modification and analysis. Nat. Protoc. 1 (2006), 2353–2364, 10.1038/nprot.2006.324.
26. [26] Duarte-Pereira, S., Paiva, F., Costa, V.L., Ramalho-Carvalho, J., Savva-Bordalo, J., Rodrigues, Â., et al. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma. Eur. J. Cancer 47 (2011), 1106–1114, 10.1016/j.ejca.2010.12.025.
27. [27] Lanari, C., Lamb, C.A., Fabris, V.T., Helguero, L.A., Soldati, R., Bottino, M.C., et al. The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr. Relat. Cancer 16 (2009), 333–350, 10.1677/ERC-08-0244.
28. [28] Aydoğdu, E., Katchy, A., Tsouko, E., Lin, C.-Y., Haldosén, L.-A., Helguero, L., et al. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Carcinogenesis 33 (2012), 1502–1511, 10.1093/carcin/bgs161.
29. [29] Lindberg, K., Helguero, L.A., Omoto, Y., Gustafsson, J.-Å., Haldosén, L.-A., Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity. Breast Cancer Res., 13, 2011, 10.1186/bcr2865.
30. [30] Giulianelli, S., Cerliani, J.P., Lamb, C.A., Fabris, V.T., Bottino, M.C., Gorostiaga, M.A., et al. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: a role for the FGF-2/FGFR-2 axis. Int. J. Cancer 123 (2008), 2518–2531, 10.1002/ijc.23802.
31. [31] Vogel, C., Marcotte, E.M., Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13 (2012), 227–232, 10.1038/nrg3185.
32. [32] Maier, T., Güell, M., Serrano, L., Correlation of mRNA and protein in complex biological samples. FEBS Lett. 583 (2009), 3966–3973, 10.1016/j.febslet.2009.10.036.
33. [33] Iwaya, T., Fukagawa, T., Suzuki, Y., Sudo, T., Ishida, K., Kume, K., et al. Abstract 5201: MicroRNA 760 regulates gastric cancer progression by downregulation of histone mRNA expression. Cancer Res., 74, 2014, 10.1158/1538-7445.AM2014-5201 5201–5201.